Global Health Supply Chain Reaches 71% On-Time Delivery, with 97% Delivered in Full
06 déc. 2017 15h23 HE
|
Chemonics
Washington, D.C., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Chemonics International announced this week that the USAID Global Health Supply Chain Program – Procurement and Supply Management (GHSC-PSM)...
New Testing Procedure Holds Promise As a Critical Tool in the Global Effort to Eliminate Malaria
24 avr. 2017 03h30 HE
|
Meridian Bioscience, Inc.
CINCINNATI, April 24, 2017 (GLOBE NEWSWIRE) -- As the global community gathers for World Malaria Day to celebrate successes and plot strategy to eliminate the disease from the face of the earth, a...
ECCMID Presentation to Demonstrate Revolutionary Breakthrough in Malaria Detection
17 avr. 2017 05h30 HE
|
Meridian Bioscience, Inc.
VIENNA, Austria, April 17, 2017 (GLOBE NEWSWIRE) -- Leading malaria researcher Tom van Gool’s presentation at the 27th European Congress for Clinical Microbiology and Infectious Diseases (ECCMID)...
Meridian Malaria Test Wins Prestigious Innovation Award
30 août 2016 09h46 HE
|
Meridian Bioscience, Inc.
illumigene® Malaria Receives 1st Place Award at theJournées Internationales de Biologie /Association des Colloques Nationaux des Biologistes Conference in Paris CINCINNATI, Aug. 30, 2016 (GLOBE...
Plandai Biotechnology to Use "Trojan Horse" to Make Highly Bioavailable Products Even Stronger
20 janv. 2015 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - January 20, 2015) - Plandaí Biotechnology (OTCQB: PLPL) proved in a bioavailability study performed at North West University in South Africa, that its green tea Phytofare®...
Plandai Biotechnology Could Offer Potential Anti-Viral Protection With Phytofare(TM) Catechin Complex Entrapped in Pheroid(R)
18 nov. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - November 18, 2014) - Plandaí Biotechnology (OTCQB: PLPL) entered into an agreement late last year with North West University in South Africa, that will allow it to use the...
Plandai Biotechnology's Technology Could Prove Potent in Battling Alzheimers Disease
21 oct. 2014 09h00 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - October 21, 2014) - In the recently released preliminary results from Plandaí Biotechnology's (OTCQB: PLPL) human clinical trial that compared its green tea extract to a...
New Report Shows Plandai Biotechnology's Diabetes Research More Important Than Ever
19 nov. 2013 08h30 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 19, 2013) - Late last week the International Diabetes Federation (IDF) released a report filled with some staggering statistics in the fight against diabetes....
Plandai Biotechnology's Move Into Medical Marijuana Research Gets Validation With New Study
14 nov. 2013 08h30 HE
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 14, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) and its subsidiary, Cannabis Biosciences, Inc., received a strong validation for their move into medical...
Plandai Biotechnology, Inc. to Enter Medical Marijuana Field With Phyto Cannabinoid Extract
30 oct. 2013 09h00 HE
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Oct 30, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...